Considering the abovementioned reports, we sought to investigate whether serum S1P and ceramide-Ab are altered in our well characterized cohort of OSA patients and whether they are associated with OSA severity, specific clinical parameters, and comorbidities such as coronary heart disease, diabetes mellitus and hypertension. This evidence concerns the gene MBTPS1 and obstructive sleep apnea syndrome.